Catalyst Pharmaceuticals 2021 SASB Sustainability Index

Catalyst Pharmaceuticals' 2021 SASB Index documents the company's clinical trial safety management, regulatory compliance, and access to medicines initiatives. The disclosure covers vendor qualification standards aligned with ICH guidelines and FDA regulations, FDA inspection results, and programs to ensure patient access to FIRDAPSE® regardless of ability to pay through expanded access and patient support programs.